Angioplasty Balloons Market Research Report - Forecast till 2027

Angioplasty Balloons Market: By Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

ID: MRFR/HC/8136-HCR | February 2021 | Region: Global | 153 Pages         

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Angioplasty Balloons Market, by Product Type

1.1.2. Global Angioplasty Balloons Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.3. Research Objective

2.4. List of Assumptions & Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Research Methodology for Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution and Sales

5.2.4. Post Sales Services

5.3. Impact of COVID-19 on Angioplasty Balloons Market

5.3.1. Impact on Raw Material Supply

5.3.2. Impact on Growth Rate

5.3.3. Impact on R&D and Product Pipeline

5.3.4. Impact on Regions and Countries

5.3.5. Opportunities and Threats

6. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Normal Balloons

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Cutting Balloons

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Drug Eluting Balloons

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Scoring Balloons

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION

7.1. Overview

7.2. Coronary Artery Disease

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Peripheral Artery Disease

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER

8.1. Overview

8.2. Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Cardiac Catheterization Laboratories

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. UK

9.3.1.4. Italy

9.3.1.5. Spain

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Company Share Analysis

10.4. Competitor Dashboard

10.5. Major Growth Strategy in the Global Angioplasty Balloons Market

10.6. Competitive Benchmarking

10.7. Leading Player in terms of Number of Developments in the Global Angioplasty Balloons Market

10.8. Key Developments & Growth Strategies

10.8.1. New Product Launch

10.8.2. Merger & Acquisition

10.8.3. Joint Ventures

10.9. Major Players Financial Matrix & Market Ratio

10.9.1. Sales & Operating Income 2019

10.9.2. Major Players R&D Expenditure 2019

11. COMPANY PROFILES

11.1. Biotronik SE & Co. KG

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Boston Scientific Corporation

11.3. C.R. Bard (BD)

11.4. Cook

11.5. Cordis (Cardinal Health)

11.6. Endocor

11.7. Koninklijke Philips N.V.

11.8. Medtronic

11.9. Terumo Medical Corporation

11.10. Abbott

11.11. B. Braun Melsungen AG

11.12. Others

12. APPENDIX

12.1. References

12.2. Related Reports

 

LIST OF TABLES

TABLE 1 GLOBAL ANGIOPLASTY BALLOONS MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL ANGIOPLASTY BALLOONS MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL ANGIOPLASTY BALLOONS MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 10 US: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 11 US: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 12 US: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 13 CANADA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 14 CANADA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 15 CANADA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 19 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 20 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 21 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 25 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 26 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 27 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 28 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 29 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 30 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 31 UK: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 32 UK: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 33 UK: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 34 ITALY: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 35 ITALY: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 36 ITALY: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 37 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 38 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 39 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 40 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 41 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 42 REST OF WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 43 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 44 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 45 EASTERN EUROPE: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 48 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 49 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 50 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 51 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 52 CHINA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 53 CHINA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 54 CHINA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 55 INDIA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 56 INDIA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 57 INDIA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 58 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 59 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 60 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 61 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 62 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 63 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 64 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 65 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 66 REST OF ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 67 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 68 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 69 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 70 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 71 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 72 MIDDLE EAST: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 73 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)

TABLE 74 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 75 AFRICA: ANGIOPLASTY BALLOONS MARKET, BY END USER, 2020–2027 (USD MILLION)

 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANGIOPLASTY BALLOONS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANGIOPLASTY BALLOONS MARKET

FIGURE 4 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY PRODUCT TYPE, 2019 (%)

FIGURE 5 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY APPLICATION, 2019 (%)

FIGURE 6 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY END USER, 2019 (%)

FIGURE 7 GLOBAL ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 8 AMERICAS: ANGIOPLASTY BALLOONS MARKET SHARE BY REGION, 2019 (%)

FIGURE 9 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 10 EUROPE: ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 11 WESTERN EUROPE: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 ASIA-PACIFIC: ANGIOPLASTY BALLOONS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 14 GLOBAL ANGIOPLASTY BALLOONS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 15 BIOTRONIK SE & CO. KG: KEY FINANCIALS

FIGURE 16 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE

FIGURE 17 BIOTRONIK SE & CO. KG: REGIONAL REVENUE

FIGURE 18 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS

FIGURE 19 BOSTON SCIENTIFIC CORPORATION.: SEGMENTAL REVENUE

FIGURE 20 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE

FIGURE 21 C.R. BARD (BD): KEY FINANCIALS

FIGURE 22 C.R. BARD (BD): SEGMENTAL REVENUE

FIGURE 23 C.R. BARD (BD): REGIONAL REVENUE

FIGURE 24 COOK: KEY FINANCIALS

FIGURE 25 COOK: SEGMENTAL REVENUE

FIGURE 26 COOK: REGIONAL REVENUE

FIGURE 27 CORDIS (CARDINAL HEALTH): KEY FINANCIALS

FIGURE 28 CORDIS (CARDINAL HEALTH): SEGMENTAL REVENUE

FIGURE 29 CORDIS (CARDINAL HEALTH): REGIONAL REVENUE

FIGURE 30 ENDOCOR: KEY FINANCIALS

FIGURE 31 ENDOCOR: SEGMENTAL REVENUE

FIGURE 32 ENDOCOR: REGIONAL REVENUE

FIGURE 33 KONINKLIJKE PHILIPS N.V.: KEY FINANCIALS

FIGURE 34 KONINKLIJKE PHILIPS N.V.: SEGMENTAL REVENUE

FIGURE 35 KONINKLIJKE PHILIPS N.V.: REGIONAL REVENUE

FIGURE 36 MEDTRONIC: KEY FINANCIALS

FIGURE 37 MEDTRONIC: SEGMENTAL REVENUE

FIGURE 38 MEDTRONIC: REGIONAL REVENUE

FIGURE 39 TERUMO MEDICAL CORPORATION: KEY FINANCIALS

FIGURE 40 TERUMO MEDICAL CORPORATION: SEGMENTAL REVENUE

FIGURE 41 TERUMO MEDICAL CORPORATION: REGIONAL REVENUE

FIGURE 42 ABBOTT: KEY FINANCIALS

FIGURE 43 ABBOTT: SEGMENTAL REVENUE

FIGURE 44 ABBOTT: REGIONAL REVENUE

FIGURE 45 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 46 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 47 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

Angioplasty Balloons Market

Angioplasty Balloons Market size is anticipated to hold a value of USD 3457.35 Million by 2027 and is expected to register a CAGR of 5.01% during the assessment period

Segmentation

By Product Type Normal Balloons Cutting Balloons Drug Eluting Balloons Scoring Balloons
Application Coronary Artery Disease Peripheral Artery Disease
End User Hospitals Cardiac Catheterization Laboratories Ambulatory Surgical Centers Others

Key Players

  • Abbott (US)
  • Braun Melsungen AG (Germany)
  • R. Bard (BD) (US)
  • Biotronik SE & Co. KG (Germany)
  • Boston Scientific Corporation (US)
  • Cordis (Cardinal Health) (US)
  • Cook (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (Ireland)
  • Terumo Medical Corporation (Japan)
  • Endocor (Germany)

Drivers

  • Rise in the number of collaborations and tie-ups
  • Rise in the incidence rates of cardiac diseases
  • Rise in clinical trial candidates
  • Increasing technological advancements and incorporation of innovation in the industry
  • High investment in research and development
  • Growing awareness
Speak to Analyst Request a Free Sample

Angioplasty Balloons Market Forecast:


Angioplasty Balloons Market size is anticipated to hold a value of USD 3457.35 Million by 2027 and is expected to register a CAGR of 5.01% during the assessment period of 2020 to 2027.


Market Synopsis


With increasing cases of artery diseases, balloon angioplasty has become the method of choice to treat patients suffering from coronary and peripheral artery diseases. Cardiac diseases are rising at an enormous rate, and this calls for precise treatment alternatives with high success rates. Each year cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).


Market Influencer


The companies operating in the angioplasty balloons market are focused on developing high-quality products incorporating cutting edge technologies. Also, established players are investing in clinical trials for the differentiation of products. Such initiatives promise a massive level of growth in the market. In addition to that, the increasing trend of minimally invasive procedures for the treatment of peripheral and coronary artery ailments is set to boost the market growth over the forecast period.


Market Drivers



  • Rise in the number of collaborations and tie-ups by prominent players. For instance, in February 2017, QT Vascular (Singapore) signed a definitive agreement with Medtronic for the worldwide distribution of its Chocolate percutaneous transluminal angioplasty (PTA) catheter for five years and automatically renewable for two additional one-year periods.



  • Rise in the incidence rates of cardiac diseases in developing as well as developed countries



  • Rise in clinical trial candidates can boost the growth rate of the market during the assessment period. For instance, in November 2018, Koninklijke Philips N.V. (Netherlands) commenced patient enrolment for its Stellarex ILLUMENATE below-the-knee (BTK) investigational device exemption (IDE) clinical trial in the US. This study will compare the safety and effectiveness of the Stellarex 0.014 drug-coated angioplasty balloon to percutaneous transluminal angioplasty (PTA) in critical limb ischemia (CLI) patients.



  • Increasing technological advancements and incorporation of innovation in the industry



  • High investment in research and development



  • Growing awareness created by medical professionals and key players about the benefits of angioplasty balloons


Market Restraints



  • Product Recalls. In June 2019, Cook recalled three models of a balloon catheter used for leg angioplasty procedures after receiving multiple complaints of balloons bursting below the device's rated burst pressure.



  • Side-effects and complications can reduce the preference rate


Segmentation


By Product Type



  • Normal Balloons: The wide usage and availability of normal balloons contribute to the largest market share of this segment. Also, the reasonable cost of these products coupled with the favorable regulatory approval procedures is set to be a major contributor to the segment growth.



  • Cutting Balloons: With the cutting balloon, the increase in the vessel lumen diameter is obtained in a more controlled manner and with a lower balloon inflation pressure than conventional balloons. This controlled dilatation could reduce the extent of vessel wall injury and the incidence of restenosis. This segment has been gaining popularity due to its high benefits and as a result, an increased preference rate. Thus, such factors are expected to drive the segment growth.



  • Drug-Eluting Balloons: This segment is anticipated to be the fastest-growing during the assessment period owing to the increasing strategic initiatives taken by prominent players in the market. For instance, in August 2018, B. Braun Melsungen AG announced that its drug-coated balloon ‘SeQuent Please’ for percutaneous transluminal coronary angioplasty showed positive results in the BASKET-SMALL 2 clinical trial.



  • Scoring Balloons: The increasing use of scoring balloons acts as a major reason for the growth of this segment. Several prominent companies are involved in the manufacturing of scoring balloons for coronary artery For instance, Koninklijke Philips N.V. (Netherlands) manufactures AngioSculpt PTCA, a scoring balloon that significantly highlights the landscape for treating coronary artery disease.


By Application



  • Coronary Artery Disease: The coronary artery disease segment held the largest share in 2019 owing to the increasing rate of cardiac diseases across the globe. For instance, cardiovascular disease accounts for 45% of all deaths in Europe. Such high statistics push the treatment rate for coronary artery disease, resulting in the growth of the segment.



  • Peripheral Artery Disease: This segment is expected to be the fastest-growing during the forecast period. The increased occurrences of peripheral artery diseases in developing countries are likely to boost the growth of the market. Also, rising product launches by key players significantly contribute to the growth of the market. For instance, in October 2019, introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio. These balloons broaden physicians’ treatment options for peripheral artery disease patients with a high risk of restenosis.


By End-User



  • Hospitals: Hospitals held the majority share in 2018 owing to the high success rates of coronary and peripheral angioplasty procedures carried out in a hospital. On average, 200,000 cardiac arrests occur each year in hospitals in the US. Such strong statistics promises the growth of this segment in the coming years.



  • Cardiac Catheterization Laboratories: This segment is anticipated to be the fastest-growing during the forecast period owing to the rising cardiac intervention procedures conducted in these labs. The high uptake and adoption of patients and medical professionals towards the use of such labs boost the growth of this segment. For instance, more than one million diagnostic cardiac catheterizations (excluding percutaneous coronary intervention–only procedures) are performed each year in the nearly 2,000 cardiac catheterization laboratories in the US.



  • Ambulatory Surgical Centers: The surging incidence rates of peripheral artery push for faster treatment access and alternatives. The reduced turnaround time that ambulatory surgical centers provide to the patients is driving the growth of this segment.



  • Others: Others include academic organizations, and research firms, simulation centers.


By Region



  • Americas: Americas held the largest market share in 2019, owing to the presence of major players, such as Boston Scientific Corporation and Cardinal Health. Also, several companies are entering into tie-ups to expand their geographical footprints, leading to an increase in the market share of the Americas angioplasty balloons market.



  • Europe: The European region holds the second largest share owing to a surging case of hospitalizations for techniques such as carotid artery angioplasty and cerebral angioplasty. Also, there are a substantial number of major players in the European countries who focus on strategic moves, including joint ventures, mergers, and acquisitions to strengthen their presence in the market space. For instance, in August 2017, Koninklijke Philips N.V. (Netherlands) completed the acquisition of Spectranetics Corporation, a US-based global leader in vascular intervention and lead management solutions.



  • Asia-Pacific: The Asia-Pacific region is predicted to be the fastest-growing region in the global angioplasty balloons market. Vigorous marketing activities by the manufacturers are playing a substantial role in increasing the potential targets, thus increasing the market size in this region. For instance, in August 2018, Medtronic (Ireland) started selling its IN.PACT Admiral drug-coated balloon (DCB) in Japan, thus increasing the Japan angioplasty balloons market share in the APAC region.



  • Middle East & Africa: This region holds the least share but is likely to rise in the near future due to the inclination of prominent companies to untapped regions.


Key Players



  • Abbott (US)

  • Braun Melsungen AG (Germany)

  • R. Bard (BD) (US)

  • Biotronik SE & Co. KG (Germany)

  • Boston Scientific Corporation (US)

  • Cordis (Cardinal Health) (US)

  • Cook (US)

  • Koninklijke Philips N.V. (Netherlands)

  • Medtronic (Ireland)

  • Terumo Medical Corporation (Japan)

  • Endocor (Germany)



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 3457.35 Million
  CAGR   5.01% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   B. Braun Melsungen AG (Germany), Abbott (US), Biotronik SE & Co. KG (Germany), C.R. Bard (BD) (US), Boston Scientific Corporation (US), Cook (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Terumo Medical Corporation (Japan), Cordis (Cardinal Health) (US), and Endocor (Germany).
  Key Market Opportunities   Increasing Trend of Minimally Invasive Procedures for the Treatment of Peripheral and Coronary Artery Ailments is set to boost the Market Growth over the Forecast Period.
  Key Market Drivers

  • Rise in the number of Collaborations and tie-ups by Prominent Players.
  • Rise in the Incidence Rates of Cardiac Diseases in developing as well as developed countries.
  • Rise in Clinical Trial candidates can boost the growth rate of the market during the assessment period.\r\n


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The upswing in cardiac ailment is likely to spur the market in the impending period.

    A 5% CAGR is estimated to enable the market to achieve high growth in the future.

    A USD 3457.35 Million is estimated to prompt positive growth in the market.

    The Americas' regional market is estimated to be in the spotlight in the upcoming period.

    Boston Scientific Corporation (US), Cordis (Cardinal Health) (US), Cook (US), Biotronik SE & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands)are inducing significant growth in the market.